Abstract
Objective: to evaluate calculation method for performing an optimal patch size, as well as to assess the degree of functioning of the formed locking element.
Material and methods. to evaluate calculation method for performing an optimal patch size, as well as to assess the degree of functioning of the formed locking element.
Results. Statistically significant differences between the groups in the estimated parameters were revealed on the 3rd postoperative day. On the 7th day, the values of longitudinal and circular myocardial deformity did not differ significantly between the study groups. Radial deformation and mechanical dispersion had significant intergroup differences. To determine the diagnostic value of the parameters of the mechanical function of the heart for the risk of developing acute heart failure, an ROC analysis was performed. For longitudinal deformation of the myocardium, the result of calculating the area under the ROC curve (AUC) was 0.881 with a critical value of –17%, for radial deformation AUC – 0.863 with a critical value of 47.5%, for mechanical dispersion – 0.752 with a critical value of 23 ms. The lowest diagnostic value was found in the index of circular deformity – 0.646 with a critical point of –12.5%.
Conclusion. 1. Analysis of mechanical dispersion and left ventricular myocardium strain in patients after cardiac surgery in combination with hemodynamic and laboratory criteria for acute heart failure allows to compare the effectiveness of myocardial protection using different cardioplegic solutions. 2. The ROC analysis confirmed that mechanical dispersion and left ventricular myocardium strain can be used to evaluate the mechanical function of the myocardium and assess the effect of cardioplegia on the risk of developing acute heart failure in the early postoperative period.
References
- Mercer-Rosa L., Wei Yang, Kutty Sh., Rychik J., Fogel M., Goldmuntz E. Quantifying pulmonary regurgitation and right ventricular function in surgically repaired tetralogy of Fallot: A comparative analysis of echocardiography and magnetic resonance imaging. Circ. Cardiovasc. Imaging. 2012; 5 (5): 637–43. DOI: 10.1161/CIRCIMAGING.112.972588
- Therrien J., Provost Y., Merchant N., Williams W., Colman J., Webb G. Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair. Am. J. Cardiol. 2005; 95: 779–82. DOI: 10.1016/j.amjcard.2004.11.037
- Bacha E.A., Scheule A.M., Zurakowski D., Erickson L.C., Hung J., Lang P. et al. Long-term results after early primary repair of tetralogy of Fallot. J. Thorac. Cardiovasc. Surg. 2001; 122: 154–61. DOI: 10.1067/mtc.2001.115156
- Bradley E., Parker J., Novak E., Ludbrook P., Billadello J., Cedars A. Cardiovascular disease in late survivors of tetralogy of Fallot: a tertiary care center experience. Tex. Heart Inst. J. 2013; 40 (4): 418–23.
- Van der Ven J.P.G., van den Bosch E., Bogers A.J.C.C., Helbing W.A. Current outcomes and treatment of tetralogy of Fallot. F1000Res. 2019; 8: F1000 Faculty Rev-1530. DOI: 10.12688/f1000research.17174.1
- Llamosas-Falcón L., Bermejo-Sánchez E., Sánchez-Díaz G. et al. Tetralogy of Fallot in Spain: a nationwide registry-based mortality study across 36 years. Orphanet J. Rare Dis. 2019; 14: 79. DOI: 10.1186/s13023-019-1056-y
- Lillehey C.W., Cohen M., Warden H.E., Read R.C., Aust J.B., Dewall R.A., Varco R.L. Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases. Ann. Surg. 1955; 142 (3): 418–42.
- Cohen M., Lillehei C.W., Varco R.L., Warden H.E. Complete anatomical correction of the tetralogy of Fallot defects; report of a successful surgical case. AMA Arch. Surg. 1956; 73 (3): 526–31. DOI: 10.1001/archsurg.1956.01280030152018
- Galicia-Tornell M., Reyes-López A., Ruíz-González S., BolioCerdán A., González-Ojeda A., Fuentes-Orozco C. Tratamiento de la tetralogía de Fallot con parche transanular. Seguimiento a 6 años [Treatment of Fallot tetralogy with a transannular patch. Six years follow-up]. Cir. Cir. 2015; 83 (6): 478–84. DOI: 10.1016/j.circir.2015.06.003
- Podzolkov V.P., Kiselev N.A., Plotnikova L.R. Results of using a patch with a single-leaf for radical correction of Fallot's tetrad. Russian Journal of Thoracic and Cardiovascular Surgery. 1990; 9: 15–21 (in Russ.).
- Konstantinov B.A. The first experience of clinical use of monofilament xenopericardial grafts. Russian Journal of Thoracic and Cardiovascular Surgery. 1990; 5: 3–7 (in Russ.).
- Guo-Wei He. A new technique of transannular monocusp patch-repair of the right ventricular outflow tract in repair of tetralogy of Fallot. Heart, Lung Circ. 2007; 16: 107–12. DOI: 10.1016/j.hlc.2006.10.013
- De Martino A., Milano A.D., Bortolotti U. Use of pericardium for cardiac reconstruction procedures in acquired heart diseases – a comprehensive review. Thorac. Cardiovasc. Surg. 2021; 69 (1): 83–91. DOI: 10.1055/s-0039-1697918
- Zelenikin M.A., Volkov S.S., Narmaniya I.T., Britikov D.V. Results of reconstruction of the outflow tract of the venous ventricle with pulmonary allograft in children. Part 1. Immediate results. Bulletin of Bakoulev Center. Cardiovascular Diseases. 2018; 19 (5): 663–7 (in Russ.). DOI: 10.24022/1810-0694-2018-19-5-663-667
- Boethig D., Horke A., Hazekamp M. et al. A European study on decellularized homografts for pulmonary valve replacement: initial results from the prospective ESPOIR Trial and ESPOIR Registry data. Eur. J. Cardiothorac. Surg. 2019; 56 (3): 503–9. DOI: 10.1093/ejcts/ezz054
- Ruzmetov M., Shah J.J., Geiss D.M., Fortuna R.S. Decellularized versus standard cryopreserved valve allografts for right ventricular outflow tract reconstruction: A single-institution comparison. J. Thorac. Cardiovasc. Surg. 2012; 143 (3): 543–9. DOI: 10.1016/j.jtcvs.2011.12.032
- Nath D.S., Nussbaum D.P., Yurko Ch., Ragab O.M., Shin A.J., Ram Kumar S. Pulmonary homograft monocusp reconstruction of the right ventricular outflow tract: Outcomes to the intermediate term. Ann. Thorac. Surg. 2010; 90: 42–9. DOI: 10.1016/j.athoracsur.2010.03.045
- Xargay-Torrent S., Dorado-Ceballos E., Benavides-Boixader A., Lizárraga-Mollinedo E., Mas-Parés B., MontesinosCosta M. et al. Circulating IGF-I independently predicts blood pressure in children with higher calcium-phosphorus product levels. J. Clin. Endocrinol. Metab. 2019; 104 (11): 5285–98. DOI: 10.1210/clinem/dgz101
- Deutsch O., Bruehl F., Cleuziou J., Prinzing A., Schlitter A.M., Krane M., Lange R. Histological examination of explanted tissue-engineered bovine pericardium following heart valve repair. Interact. Cardiovasc. Thorac. Surg. 2020; 30 (1): 64–73. DOI: 10.1093/ icvts/ivz234
- Nikol'skiy V.I., Titova E.V., Fedorova M.G., Iangurazova E.V., Nikol'skiy A.V. What happens with xenopericardium long after the implantation? Khirurgiia. 2013; 7: 69–70 (in Russ.).
- Greyson C.R. Pathophysiology of right ventricular failure. Crit. Care Med. 2008; 36 (1 Suppl.): S57–65. DOI: 10.1097/01
- Naeije R., Badagliacca R. The overloaded right heart and ventricular interdependence. Cardiovasc. Res. 2017; 113 (12): 1474–85. DOI: 10.1093/cvr/cvx160
- Honda Y., Wakabayashi K., Suzuki T., Suzuki H. Does anticoagulation therapy prevent thrombosis in coronary stent grafts? Cardiovasc. Interv. Ther. 2017; 32 (4): 405–8. DOI: 10.1007/s12928-016-0443-8
- Baumann K.L., Karkouti K., Tweddell J., Massicotte M.P. Antithrombotic therapy management of adult and pediatric cardiac surgery patients. J. Thromb. Haemost. 2018; 16 (11): 2133–46. DOI: 10.1111/jth.14276
- Konuma T., Devaney E.J., Bove E.L., Gelehrter S., Hirsch J.C., Tavakkol Z., Ohye R.G. Performance of CryoValve SG decellularized pulmonary allografts compared with standard cryopreserved allografts. Ann. Thorac. Surg. 2009; 88 (3): 849–54; disc. 554-5.
- Tavakkol Z., Gelehrter S., Goldberg C.S., Bove E.L., Devaney E.J., Ohye R.G. Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts. Ann. Thorac. Surg. 2005; 80 (5): 1610–4. DOI: 10.1016/j.athoracsur.2005.04.017
About the authors
- Anastasiya V. Shcherbak, Cardiovascular Surgeon, ORCID
- Mikhail M. Zelenikin, Dr. Med. Sc., Professor, Head of Department,ORCID
- Dmitriy V. Britikov, Dr. Med. Sc., Head of Group
- Mikhail A. Zelenikin, Dr. Med. Sc., Professor, Chief Researcher, ORCID
